Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors.

Clubb JHA, Pakola SA, Joenväärä S, Kudling TV, Tohmola T, Arias V, Jirovec E, van der Heijden M, Quixabeira DCA, Pasanen A, Haybout L, Ojala N, Basnet S, Eleuteri A, Ferrero JD, Hirvenoja S, Svane IM, Mäenpää J, Jalkanen K, Block MS, Alanko T, Monberg T, Zahraoui S, Grönberg-Vähä-Koskela S, Salmelin N, Kistler C, Havunen R, Sorsa S, Manuel Dos Santos J, Cervera-Carrascon V, Kanerva A, Hemminki O, Renkonen R, Hemminki A

Open source

DOI: 10.1016/j.ymthe.2026.01.019
Published: 2026 May 6
Container: Molecular therapy : the journal of the American Society of Gene Therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ymthe.2026.01.019,
  title = {Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors.},
  author = {Clubb JHA and Pakola SA and Joenväärä S and Kudling TV and Tohmola T and Arias V and Jirovec E and van der Heijden M and Quixabeira DCA and Pasanen A and Haybout L and Ojala N and Basnet S and Eleuteri A and Ferrero JD and Hirvenoja S and Svane IM and Mäenpää J and Jalkanen K and Block MS and Alanko T and Monberg T and Zahraoui S and Grönberg-Vähä-Koskela S and Salmelin N and Kistler C and Havunen R and Sorsa S and Manuel Dos Santos J and Cervera-Carrascon V and Kanerva A and Hemminki O and Renkonen R and Hemminki A},
  year = {2026},
  journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
  doi = {10.1016/j.ymthe.2026.01.019},
  url = {https://doi.org/10.1016/j.ymthe.2026.01.019}
}

RIS

TY  - JOUR
TI  - Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors.
AU  - Clubb JHA
AU  - Pakola SA
AU  - Joenväärä S
AU  - Kudling TV
AU  - Tohmola T
AU  - Arias V
AU  - Jirovec E
AU  - van der Heijden M
AU  - Quixabeira DCA
AU  - Pasanen A
AU  - Haybout L
AU  - Ojala N
AU  - Basnet S
AU  - Eleuteri A
AU  - Ferrero JD
AU  - Hirvenoja S
AU  - Svane IM
AU  - Mäenpää J
AU  - Jalkanen K
AU  - Block MS
AU  - Alanko T
AU  - Monberg T
AU  - Zahraoui S
AU  - Grönberg-Vähä-Koskela S
AU  - Salmelin N
AU  - Kistler C
AU  - Havunen R
AU  - Sorsa S
AU  - Manuel Dos Santos J
AU  - Cervera-Carrascon V
AU  - Kanerva A
AU  - Hemminki O
AU  - Renkonen R
AU  - Hemminki A
PY  - 2026
JO  - Molecular therapy : the journal of the American Society of Gene Therapy
DO  - 10.1016/j.ymthe.2026.01.019
UR  - https://doi.org/10.1016/j.ymthe.2026.01.019
ER  -

APA

JHA, C., SA, P., S, J., TV, K., T, T., V, A., E, J., M, V. D. H., DCA, Q., A, P., L, H., N, O., S, B., A, E., JD, F., S, H., IM, S., J, M., K, J., MS, B., T, A., T, M., S, Z., S, G., N, S., C, K., R, H., S, S., J, M. D. S., V, C., A, K., O, H., R, R., & A, H. (2026). Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors.. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2026.01.019

Source records

pubmed · retrieved 2026-09-25T12:26:46.325Z
europe-pmc · retrieved 2026-09-25T12:26:46.333Z